Rankings
▼
Calendar
RLAY
Relay Therapeutics, Inc.
$2B
Q2 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$20M
Net Income
-$18M
EPS (Diluted)
$-5.28
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$17M
Stock-Based Comp.
$1M
← FY 2019
All Quarters
Q3 2019 →
RLAY Q2 2019 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
